Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
33
Number of overlapping holdings
97.1%
% of IHE's 34 holdings also in XPH
82.5%
% of XPH's 40 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 5.0% | 5.1% | 5.0% |
|
ELI LILLY & CO | 22.8% | 4.7% | 4.7% |
|
PFIZER INC | 4.7% | 4.8% | 4.7% |
|
JOHNSON & JOHNSON | 22.7% | 4.6% | 4.6% |
|
ROYALTY PHARMA PLC CLASS A | 4.6% | 4.6% | 4.6% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to XPH
|
JOHNSON & JOHNSON | 18.1% |
|
ELI LILLY & CO | 18.0% |
|
EDGEWISE THERAPEUTICS, INC. | 0.4% |
|
PRESTIGE BRANDS HOLDINGS INC | 0.0% |
|
ROYALTY PHARMA PLC CLASS A | 0.0% |
|
BRISTOL-MYERS SQUIBB CO | 0.0% |
|
VIATRIS, INC. | -0.1% |
|
PFIZER INC | -0.1% |
|
MERCK & CO. INC. | -0.1% |
|
ZOETIS INC | -0.1% |
IHE Underweight Relative to XPH
|
AXSOME THERAPEUTICS, INC. | -3.4% |
 |
PERRIGO CO | -3.2% |
|
ORGANON & CO. | -2.9% |
|
CORCEPT THERAPEUTICS INC | -2.6% |
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
PSIVIDA CORP | -2.1% |
|
CASSAVA SCIENCES, INC. | -1.9% |
|
ARVINAS, INC. | -1.7% |
|
JAZZ PHARMACEUTICALS PLC | -1.7% |
|
TARSUS PHARMACEUTICALS, INC. | -1.5% |